A stem cell-based product consisting of allogeneic mobilized peripheral blood mononuclear stem and immune cells collected by apheresis from the kidney donor.

‍

The cells are processed to reduce the numbers of mature donor T cells, which could cause Graft versus Host Disease (GvHD), while keeping the necessary hematopoietic progenitor cells and facilitating cells needed for homing and engraftment into the recipient’s marrow.

‍

For more information on FCR001, visit the resources page.